Dosage & Administration Efficacy safety testing Drug label Prior authorization Financial assistance

Sprycel

(dasatinib)

dasatinib 100 MG Oral Tablet [Sprycel]dasatinib 140 MG Oral Tablet [Sprycel]

View 4 more

NO BLACK BOX WARNING

Dosage & administration

* Chronic phase CML in adults: 100 mg once daily. (2)
* Accelerated phase CML, myeloid or lymphoid blast phase CML, or Ph+ ALL in adults: 140 mg once daily. (2)
* Chronic phase CML and ALL in pediatrics: starting dose based on body weight. (2)
* Administer orally, with or without a meal. Do not crush, cut, or chew tablets. (2)

eficacy, safety & testing

Sprycel clinical details

Clinical Trial: Treatment-Naïve CP Ph+ CML, Adults

Efficacy: Treatment-Naïve CP Ph+ CML, Adults

Clinical Trial: Imatinib-Resistant or Intolerant CP Ph+ CML, Adults

Efficacy: Imatinib-Resistant or Intolerant CP Ph+ CML, Adults

Safety Profile: Treatment-Naïve CP Ph+ CML, Adults

Safety Profile: Imatinib-Resistant or Intolerant CP Ph+ CML, Adults

Select Safety Management

Dosing

Efficacy: Pediatric

Safety Profile: Pediatric

Dosing: Pediatric

drug label

Sprycel prescribing information

Have more Sprycel questions?

Submit MSL Request

Learn More

Need to report a Sprycel issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Sprycel Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

Coverage Authorization Appeals

Commercial Claim Denial Appeal/Redetermination Letter

Medically Unlikely Edit (MUE) Appeal Letter

Learn More

Benefits investigation

Sprycel Enrollment Form

Sprycel Enrollment Form - Spanish

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Sprycel Financial assistance options

Co-pay savings program

commercial only

Sprycel Enrollment Form

Sprycel Enrollment Form - Spanish

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Sprycel Enrollment Form

Sprycel Enrollment Form - Spanish

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Sprycel Patient education

Getting started on Sprycel

NOT PROVIDED BY BRANDInstructions For Use: Adult Ph+ CML

NOT PROVIDED BY BRANDInstructions For Use: Pediatric Ph+ CML